Search clinical trials for: CMV seropositive (R )

Total 637 results

Memorial Sloan Kettering Cancer Center
Atara Biotherapeutics

Completed

Primary Transplant Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation

Cytomegalovirus

United States
University of Erlangen-Nürnberg Medical School
German Research Foundation; Charite University, Berlin, Germany; Ludwig-Maximilians... and other collaborators

Completed

Preventative/Preemptive Adoptive Transfer of Peptide Stimulated CMV/EBV Specific T-cells in Patients After Allogeneic Stem Cell Transplantation

Patients Undergoing Allogeneic Stem Cell Transplantation

Germany
Fundación para la Investigación del Hospital Clínico...

Completed

Pre-engraftment Cytomegalovirus DNAemia

CMV DNAemia Pre-engraftment

Spain
Kirby Institute
National Institute of Allergy and Infectious Diseases (NIAID); ViiV Healthcare and other collaborators

Withdrawn

Inflammation and Co-Infections in D²EFT (i2-D²EFT)

Cytomegalovirus Infections | Human Papilloma Virus | HIV-infection/Aids | Human Herpesvirus 4 Infections | Human Herpesvirus 8 Infection
University of Zimbabwe
University Hospital Inselspital, Berne; University of Oxford; Wellcome Trust; University... and other collaborators

Unknown

The University of Zimbabwe College of Health Science (UZ-CHS) BIRTH COHORT Study (UZ-CHS-BC)

HIV Infections | Immune Activation | Comorbidities
University of Tennessee, Chattanooga

Withdrawn

Airway Pressure Release Ventilation (APRV) Compared to ARDSnet Ventilation (PRESSURE)

Acute Lung Injury | Kidney Injury | Adult Respiratory Distress Syndrome

United States
PTC Therapeutics

Completed

Safety and Biomarker Study of EPI-589 in Participants With Amyotrophic Lateral Sclerosis (ALS) (EPI-589)

Amyotrophic Lateral Sclerosis

United States
Peking University People's Hospital

Unknown

The Molecular Mechanism of CMV-driven NKG2C+NK Cell Expansion in Human

Acute Leukemia | Hematopoietic Stem Cell Transplantation | CMV Viremia

China
QIAGEN Gaithersburg, Inc

Terminated

Clinical Evaluation of the QuantiFERON CMV Assay

CMV

United States
National Institute of Mental Health (NIMH)

Terminated

PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)

HIV Infections | Healthy | AIDS Dementia Complex | AIDS-Related Dementia Complex | HIV-Associated Cognitive Motor Complex | HIV-Dementia | AIDS Encephalopathy

United States
Dr. Soliman Fakeeh Hospital

Completed

Effect of Slow Injection of Fentanyl on the Incidence of Spinal Anesthesia Induced Itching in Cesarean Section

Itching
University Hospital, Grenoble

Completed

Anti-CMV Cellular Immunity Quantification Using an IGRA Test in Kidney Transplant récipients and Hemodialysis Patients, Comparison to Control Patients (Quantiferon)

Hemodialysis | Kidney Transplant Infection | Cytomegalovirus Infections | Quantiferon-CMV

France
University of California, San Francisco
Roche Pharma AG

Completed

Valganciclovir to Reduce T Cell Activation in HIV Infection

HIV Infections | Cytomegalovirus Infections

United States
Medy-Tox

Completed

Evaluate the Efficacy and Safety of MEDITOXIN in Treatment of Primary Axillary Hyperhidrosis

Hyperhidrosis Primary Focal Axilla

Korea, Republic of
Children's National Research Institute
M.D. Anderson Cancer Center

Completed

Cytotoxic T Cells to Prevent Virus Infections

CMV | EBV | Adenovirus Infections

United States
Aveiro University
Fundação para a Ciência e a Tecnologia

Completed

(Re)Vitalizing Pulmonary Rehabilitation for Patients With Chronic Respiratory Diseases (3R)

Chronic Respiratory Disease

Portugal
GlaxoSmithKline

Completed

Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus

Cytomegalovirus Infections | Infections, Cytomegalovirus

Belgium
University of Alabama at Birmingham

Completed

Evaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) Infection

Cytomegalovirus Infections

United States
Hospital Universitari Vall d'Hebron Research Institute

Unknown

Management of Cytomegalovirus (CMV) Infection in Lung Transplant Recipients (LTR)

Lung Transplant; Complications
VBI Vaccines Inc.
Clinical Trial Data Services, LLC

Completed

Study to Evaluate Safety, Tolerability, and Immunogenicity of Candidate Human Cytomegalovirus Vaccine in Healthy Adults

Cytomegalovirus Infections

Canada
Seoul National University Hospital

Completed

Clinical Trial of Minimally Invasive Robotic Spine Surgery

Degenerative Lumbar Spinal Stenosis

Korea, Republic of
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Immunogenicity of the RSV D46cpΔM2-2 Vaccine in RSV-Seropositive Children and RSV-Seronegative Infants and Children

Respiratory Syncytial Virus Infections

United States
Christine Mauz-Körholz
Deutsche Krebshilfe e.V., Bonn (Germany); Euronet Worldwide

Completed

Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma

Lymphoma

United Kingdom, Germany
Gary Archer Ph.D.
Bristol-Myers Squibb; Duke Cancer Institute

Completed

Nivolumab With DC Vaccines for Recurrent Brain Tumors (AVERT)

Glioblastoma | Astrocytoma | Malignant Glioma

United States
University College, London
GlaxoSmithKline; Medical Research Council; University of Oxford

Completed

Depletion of Serum Amyloid P Component to Enhance the Immune Response to DNA Vaccination (HIV-CORE003)

HIV

United Kingdom
Yae-Jean Kim
Miltenyi Biotec B.V. & Co. KG

Withdrawn

Adoptive Transfer of pp65-specific T Cells for the Treatment of Refractory Cytomegalovirus (CMV) Infection

Cytomegalovirus Infections

Korea, Republic of
M.D. Anderson Cancer Center
Miltenyi Biotec B.V. & Co. KG

Completed

Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation

Lymphoma | Leukemia

United States
Hoffmann-La Roche

Completed

A Study of Valcyte (Valganciclovir) CMV Prophylaxis After Renal Transplantation

Cytomegalovirus Infections

Germany, Austria
Memorial Sloan Kettering Cancer Center

Completed

Trial of Donor T Cells Sensitized With Pentadecapeptides of the CMV-PP65 Protein for the Treatment of Cytomegalovirus (CMV) Infections Following Allogeneic Hematopoietic Stem Cell Transplants

Cytomegalovirus Infections

United States
Peking University People's Hospital

Completed

Preemptive Therapy With CMV-specific T Cells Infusion to Prevent Refractory CMV Infection Post Transplantation

CMV Infection

China
Bristol-Myers Squibb

Completed

A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet Formulation

Systemic Lupus Erythematosus | Inflammatory Bowel Diseases | Psoriasis | Arthritic Psoriasis

United States
Fundación de investigación HM
Merck Sharp & Dohme LLC

Unknown

Cytomegalovirus Infection in Critically Ill Patients and Patients Receiving Anticancer Therapy (CMV-ICU)

CMV
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant

Acute Myeloid Leukemia | Hodgkin Lymphoma | Waldenstrom Macroglobulinemia | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | Plasma Cell Myeloma | Myelodysplastic/Myeloproliferative Neoplasm | Graft Versus Host Disease | Chronic Myelogenous Leukemia, BCR-ABL1 Positive

United States, Italy
Dr Cipto Mangunkusumo General Hospital

Unknown

Effect of Atorvastatin on Subclinical Atherosclerosis

CMV

Indonesia
Asan Medical Center

Completed

Assessment of CMV-specific ELISPOT Assay for Predicting CMV Colitis in Patient With Ulcerative Colitis (ACE-UC)

Ulcerative Colitis | Cytomegalovirus Infections | Disease Exacerbation

Korea, Republic of
GlaxoSmithKline

Completed

Evaluation of the Long-term Persistence of GlaxoSmithKline (GSK) Biologicals' Candidate Cytomegalovirus (CMV) Vaccine

Infections, Cytomegalovirus

Belgium
Acrotech Biopharma Inc.

Completed

Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies

B-cell Lymphoma | Hodgkin's Lymphoma | Relapsed or Refractory Lymphoproliferative Malignancies | Peripheral T-cell Lymphoma | Waldenstrom's Macroglobulinemia

United States
Acrotech Biopharma Inc.

Completed

Study of Pralatrexate in Female Patients With Previously-treated Breast Cancer

Breast Cancer | Breast Tumors | Neoplasms, Breast | Cancer of the Breast | Human Mammary Carcinoma

France, United States, Czechia, Hungary
Acrotech Biopharma Inc.

Completed

Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PROPEL)

Peripheral T-cell Lymphoma

United States, United Kingdom, Canada, France, Italy, Belgium
Acrotech Biopharma Inc.

Completed

Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma

Mycosis Fungoides | Sezary Syndrome | Cutaneous T-cell Lymphoma | Primary Cutaneous Anaplastic Large Cell Lymphoma

United States, Italy
University of Erlangen-Nürnberg Medical School

Terminated

The Influence of TaKeTiNa Music Therapy, Traditional Chinese Acupuncture and Clown Theatrical Performance on Quality of Life and the Therapeutic Process of Patients Undergoing Allogenic Stem Cell Transplantation (TriCAM)

Depression | Quality of Life | Leukemia | Graft-Versus-Host Disease | Stem Cell Transplant Complications | Hematological Neoplasm

Germany
Acrotech Biopharma Inc.

Completed

Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder

Carcinoma, Transitional Cell | Bladder Cancer | Bladder Neoplasm

Spain, France, Belgium, United States, Argentina, Croatia
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Phase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Transplant Viral Infections

Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | MDS (Myelodysplastic Syndrome) | CML (Chronic Myelogenous Leukemia) | AML (Acute Myelogenous Leukemia)

United States
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Acute Partner and Social Contact Referral: iKnow

Sexually Transmitted Infections | Acute HIV Infection | HIV Seropositive

United States
Assistance Publique - Hôpitaux de Paris

Terminated

Evaluation of the Benefit of Antiviral Treatment With Valganciclovir on Congenital CMV Infection-related Deafness on Hearing and Balance (GANCIMVEAR)

Congenital Cytomegalovirus (CMV)

France
Shaare Zedek Medical Center

Unknown

The Maternal Cellular Immune System and Cytomegalovirus Intrauterine Infection

Pregnant Women | Cytomegalovirus Infections

Israel
University of Minnesota

Completed

Treating Kidney Donors With Valganciclovir to Reduce Viral Transmission to Recipients

CMV Viremia | EBV Viremia

United States
Royal Brompton & Harefield NHS Foundation Trust
University of Bristol; National Institute for Health Research, United Kingdom

Unknown

Mesothelioma and Radical Surgery 2 (MARS2)

Mesothelioma

United Kingdom
University Hospital, Limoges

Terminated

Assessing the Risk of CMV Infection of the Renal Transplant About R + by Cellular Immunity Analyzed by the QuantiFERON ®-CMV Test. (QUANTIC-R+)

Renal Transplant Recipient | Immunized Against the Cytomegalovirus

France
University Hospital, Limoges

Completed

A French Cohort of Transplant Recipients With CMV Infection : Risk Factors for Antiviral Resistance in the Prophylaxis Era. (ORPHAVIC)

Transplant Recipients With CMV Infection

France

Search clinical trials for: CMV seropositive (R )

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Philippines

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations